FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets

83,684 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 43800 - 44000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1090.jsonSyphilis [Congenital] (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1091.jsonCataracts [Nonspecific]/Congenital glaucoma [Unspecified Cause] (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1092.jsonCongenital heart disease (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1093.jsonHearing impairment (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1095.jsonMicrocephaly (SNOMED)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1096.jsonDevelopmental delay (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1099.jsonCongenital heart disease (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1100.jsonHearing impairment (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1104.jsonDevelopmental delay (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1106.jsonListeriosis (Tests for Listeria monocytogenes Nucleic Acid in Specimen from Normally Sterile Site)active2023-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.112.jsonTetanus (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1130.jsonTickborne Relapsing Fever (Tests for Borrelia hermsii/miyamotoi/parkerii/turicatae Nucleic Acid)active2024-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1131.jsonLyme Disease (Tests for Borrelia afzelii/garinii IgG Antibody by Immunoassayactive2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1138.jsonStaphylococcus Aureus (Tests by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1139.jsonVISA/VRSA (Tests for Vancomycin Resistance Gene)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1145.jsonResistant Lab Result Valueactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1148.jsonTests for Vancomycin Susceptibility [Ord]active2024-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1149.jsonProteinuria (Tests for Total Protein in 24H Urine)active2024-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.115.jsonMumps (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1150.jsonThrombocytopenia (Tests for Platelets [#/volume] in Blood)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1156.jsonStaphylococcus aureus (Organism or Substance in Lab Results)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1169.jsonChikungunya Virus Disease (Tests for Chikungunya virus Nucleic Acid)active2023-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.117.jsonMumps (Disorders) (ICD10CM)active2024-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1180.jsonChikungunya Virus Disease (Tests for Chikungunya Virus Antibody [Quantitative])active2024-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1186.jsonEastern Equine Encephalitis Virus Disease (Tests for Eastern Equine Encephalitis Virus Antibody [Qualitative])active2023-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1188.jsonWestern Equine Encephalitis Virus Disease (Tests for Western Equine Encephalitis Virus Antibody [Qualitative])active2024-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1196.jsonAnthrax (Tests for Bacillus cereus by Culture and Identification Method)active2024-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1197.jsonCervical Lymphadenitis (SNOMED)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1207.jsonCRE (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1212.jsonEnterobacteriaceae species [Carbapenem Resistant] (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1213.jsonNU_Enterobacteriaceae [Carbapenemase Producing] (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1214.jsonCarbapenemase resistance mechanism (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1215.jsonTests for carbapenemase productionactive2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1216.jsonTests for carbapenemase resistance mechanismactive2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1217.jsonTests for carbapenem susceptibility [Meropenem, imipenem, and doripenem]active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1218.jsonTests for carbapenem susceptibility [Ertapenem]active2024-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1219.jsonTests for Enterobacter spp., E. coli, or Klebsiella spp. by Culture and Identification Methodactive2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1220.jsonNU_Tests for Enterobacteriaceae species by Culture and Identification Methodactive2023-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1224.jsonTherapeutic Response to Medication [Improved]active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1225.jsonAltered Mental Status (SNOMED)active2023-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1230.jsonEschar (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1231.jsonHypotension (SNOMED)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1233.jsonLocalized Edema (SNOMED)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1234.jsonLocalized Edema (ICD10CM)active2024-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1237.jsonTachycardia (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1238.jsonTachycardia (ICD10CM)active2024-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1239.jsonRCKMS Conditions (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.124.jsonPoliomyelitis (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1240.jsonMaternal Condition Puerperium (SNOMED)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1242.jsonNon pestis Yersiniosis Infection (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1244.jsonBlastomycosis (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1246.jsonBlastomycosis (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1249.jsonBlastomycosis (Tests for Blastomyces species by Culture and Identification Method)active2024-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1250.jsonNon pestis Yersiniosis Infection (Tests for Yersinia non pestis species Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1251.jsonBlastomycosis (Tests for Blastomyces species Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1252.jsonBlastomycosis (Tests for Blastomyces species Antibody)active2023-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1253.jsonBlastomycosis (Tests for Blastomyces species Antigen)active2023-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1265.jsonFatigue (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1269.jsonTuberculosis [Latent Infection] (Disorders) (SNOMED)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1274.jsonHistoplasmosis (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1275.jsonHistoplasmosis (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1281.jsonHistoplasmosis (Tests for Histoplasma capsulatum H band or M band Antibody)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1294.jsonAbscess [Liver, Lung, Spleen, Prostate, or Brain] (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1295.jsonSeizure [Unspecified Cause] (SNOMED)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1298.jsonAbscess [Liver, Lung, Spleen, Prostate, or Brain] (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1299.jsonSeizure [Unspecified Cause] (ICD10CM)active2024-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.130.jsonInfluenza (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1304.jsonMycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species in Extrapulmonary Specimen by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1305.jsonMycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species Nucleic Acid in Extrapulmonary Specimen)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1306.jsonBody Temperature (Vital Sign)active2024-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1307.jsonRespiratory Rate (Vital Sign)active2024-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1309.jsonRSV (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1310.jsonRSV (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1312.jsonRSV (Tests for RSV Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1314.jsonWheezing (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1317.jsonBronchiolitis (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1325.jsonTobacco Use and Exposure (Social History)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1330.jsonTobacco Smoking Status [Current] (Social History) (LOINC)active2024-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1335.jsonHospitalized [Inpatient] (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1336.jsonCreutzfeldt Jakob Disease (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1337.jsonVariant Creutzfeldt Jakob Disease (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1340.jsonPrion Disease (Tests for 14_3_3 Protein)active2024-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1341.jsonPrion Disease (Tests for Abnormal Prion Protein)active2024-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1349.jsonCerebrospinal Fluid (Specimen Type) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.135.jsonChronic Hepatitis B Virus Infection (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1350.jsonEndocervical (Specimen Type) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1351.jsonTissue (Specimen Type) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1352.jsonSpecimen from a Normally Sterile Site (Specimen Type)(SNOMED)active2023-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1353.jsonUrethral Swab (Specimen Type) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1355.jsonWound (Specimen Type) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1359.jsonHepatitis E (Tests for hepatitis E virus IgM Antibody)active2023-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.136.jsonInvasive Pneumococcal Disease (Disorders) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1360.jsonHepatitis E (Tests for hepatitis E virus Antibody)active2024-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1363.jsonEpiglottitis (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1364.jsonOrganisms (Tests by Microscopic Observation by Gram Stain)active2024-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1369.jsonSerum (Specimen Type) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1378.jsonTests for Mycobacterium species Nucleic Acid in Unspecified XXX Specimenactive2024-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1379.jsonFish Poisoning (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1388.jsonOccupational Asthma (Disorders) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1389.jsonAsthma (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1390.jsonAsthma (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1391.jsonRespiratory Condition, due to inhalation of chemicals, gases, fumes or vapors (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1393.jsonWRA (Occupational Exposure to Potential Asthma Inducing Risk Factor) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1400.jsonColorado tick fever (Tests for Colorado Tick Fever Virus Antibody [Qualitative])active2024-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1402.jsonCancer [Malignant Neoplasms] (Disorders) (ICD10CM)active2024-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1403.jsonCancer [Benign or Borderline CNS Tumors] (Disorders) (ICD10CM)active2023-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1404.jsonCancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (ICD10CM)active2024-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1405.jsonCancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (SNOMED)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1407.jsonCancer [Malignant Neoplasms] (Disorders) (SNOMED)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1418.jsonAlpha gal syndrome (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1420.jsonAlpha gal syndrome (Tests for Alpha gal IgE Antibody [Quantitative])active2023-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1422.jsonPtosis of Eyelid [Unspecified Cause] (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1423.jsonPtosis of Eyelid [Unspecified Cause] (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1424.jsonConstipation [Unspecified Cause] (SNOMED)active2023-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1426.jsonIntubation [Respiratory Tract] (Procedure) (SNOMED)active2023-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1430.jsonInfant Botulism (Disorders) (SNOMED)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1446.jsonViral Hemorrhagic Fever [Suspected] (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1447.jsonMRSA (Disorders (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1449.jsonStaphylococcus aureus infection (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.145.jsonVaricella (Disorders) (SNOMED)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1450.jsonStaphylococcus aureus infection (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1452.jsonMRSA (Tests by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1453.jsonMRSA (Tests for Methicillin Resistance Gene)active2023-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1454.jsonStaphylococcus aureus (Tests for Staph aureus Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1458.jsonTests for Cefoxitin Susceptibility [OrdQn]active2024-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1459.jsonOrganisms (Tests in Blood by Culture and Identification)active2023-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1460.jsonBacteria (Tests in Blood by Culture and Identification Method)active2023-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1461.jsonOrganisms (Tests in Specimen from Normally Sterile Site by Culture and Identification)active2024-06ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1462.jsonStaphylococcus aureus (Tests for Staph aureus Nucleic Acid in Blood)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1463.jsonVRE (Disorders) (SNOMED)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1464.jsonVRE (Organism or Substance in Lab Results)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1465.jsonVRE (Tests by Culture and Identification Method)active2023-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1466.jsonEnterococcus species (Tests by Culture and Identification Method)active2024-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1468.jsonEnterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1469.jsonEnterococcus faecium or E. faecalis (Organism or Substance in Lab Results)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1470.jsonEnterococcus species (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1471.jsonAmebiasis (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1473.jsonAmebiasis (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1476.jsonAmebiasis (Tests for Entamoeba histolytica Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1482.jsonNorovirus (Tests for Norovirus Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1485.jsonNorovirus (Organism or Substance in Lab Results)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1487.jsonClostridioides difficile infection (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1491.jsonC. diff infection (Tests for C diff Toxin Nucleic Acid)active2024-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1492.jsonC. diff infection (Tests for C diff Toxin Nucleic Acid in Stool)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1505.jsonAcanthamoeba Disease [Keratitis] (Disorders) (SNOMED)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1507.jsonArsenic Exposure and Toxicity (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1509.jsonArsenic Exposure and Toxicity (Tests for Arsenic [Quantitative] in Unspecified Specimen)active2024-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1513.jsonUrine (Specimen Type) (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1514.jsonMercury Exposure and Toxicity (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1515.jsonCryptococcosis (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1516.jsonCryptococcosis (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1520.jsonCryptococcosis (Tests for Cryptococcus species by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1523.jsonCryptococcosis (Tests for Cryptococcus species Nucleic Acid)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1524.jsonCryptococcosis (Tests for Cryptococcus species Antigen)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1525.jsonMercury Exposure and Toxicity (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1528.jsonMercury Exposure and Toxicity (Tests for Mercury [Quantitative] in Unspecified Specimen)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1532.jsonDrug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1533.jsonDrug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1534.jsonDrug Overdose and Poisoning [Non opioid] [Cannabinoid] (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1538.jsonDrug Overdose and Poisoning [Non opioid] [Other Drug] (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.154.jsonHepatitis C Virus Infection (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1540.jsonDrug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (ICD10CM)active2024-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1541.jsonDrug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1542.jsonDrug Overdose and Poisoning [Non opioid] [Hallucinogen] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1543.jsonDrug Overdose and Poisoning [Non opioid] [Cannabinoid] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1544.jsonDrug Overdose and Poisoning [Non opioid] [Analgesic] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1545.jsonDrug Overdose and Poisoning [Non opioid] [Other Drug] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1546.jsonDrug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1551.jsonMeningitis (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1552.jsonBacterial Meningitis (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1553.jsonFungal Meningitis (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1554.jsonParasitic Meningitis (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1555.jsonBacterial Meningitis (Disorders) (ICD10CM)active2024-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1559.jsonPhotophobia (SNOMED)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1562.jsonBacteria [Causing Meningitis] (Organism or Substance in Lab Results)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1563.jsonFungi [Causing Meningitis and Encephalitis] (Organism or Substance in Lab Results)active2024-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1564.jsonViruses [Causing Meningitis] (Organism or Substance in Lab Results)active2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1565.jsonViruses [Causing Meningitis] (Tests for Nucleic Acid)active2024-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1566.jsonViruses [Causing Meningitis] (Tests for Nucleic Acid in Cerebrospinal Fluid)active2024-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1567.jsonBacteria [Causing Meningitis] (Tests by Culture and Identification Method)active2024-01ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1574.jsonInvasive Group B Streptococcus (Disorders) (ICD10CM))active2025-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1577.jsonGroup A Streptococcus (Tests for Group A Strep by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1578.jsonGroup B Streptococcus (Tests for Group B Strep by Culture and Identification Method)active2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1580.jsonAnimal Bite [Dog] (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1581.jsonAnimal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1582.jsonAnimal Bite [Excluding Mammals] (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1584.jsonAnimal Bite [Unspecified Animal] (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1585.jsonAnimal Bite [Dog] (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1586.jsonAnimal Bite [Mammal, Excluding Dogs] (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1587.jsonAnimal Bite [Excluding Mammals] (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1588.jsonCadmium Exposure and Toxicity (Disorders) (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1604.jsonVaccine Adverse Event (Disorders) (ICD10CM)active2025-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1605.jsonVaccine Adverse Event (Disorders) (SNOMED)active2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1606.jsonVaccinia disease or adverse event  (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.161.jsonVibriosis (Disorders) (SNOMED)active2023-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1612.jsonBlepharitis [Unspecified Cause] (ICD10CM)active2024-06ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1613.jsonKeratitis [Unspecified Cause] (SNOMED)active2023-06ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1614.jsonKeratitis [Unspecified Cause] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1620.jsonAnaphylaxis [Unspecified Cause] (ICD10CM)active2023-01ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1626.jsonThrombocytopenic Purpura [Unspecified Cause] (SNOMED)active2024-06ushl7sct